Cogent Biosciences
Developing precision therapies for genetically defined diseases. Learn more
Launch date
Employees
Market cap
€1.0b
Enterprise valuation
€812m (Public information from Sep 2024)
Share price
$10.9 COGT
Cambridge Massachusetts (HQ)
Authorizing premium user...